Ketamine in the News

Selected recent coverage and research about ketamine therapy.

¡Hablamos Español!

Ketamine in the News

Recent articles and stories highlighting the potential benefits of ketamine therapy.

Reuters · September 15, 2026

Psychedelic Therapies Cited by Trump: What You Need to Know

Reuters reviews the clinical and regulatory landscape after an FDA public meeting on psychedelic therapies. Most remain Schedule I in the U.S. Trials are furthest along for severe depression and PTSD. The piece also notes Spravato (esketamine) is FDA-approved for treatment-resistant depression, and that ketamine is authorized as an anesthetic and sometimes used off-label for depression. Research is moving quickly; results and access still vary.

Nature Structural & Molecular Biology · 2026

New Insights into NMDA Receptor Structure and Function

A recent paper in Nature Structural & Molecular Biology advances our understanding of NMDA receptor biology — the same receptor system central to how ketamine works in the brain.

CNN · September 2025

Can the party drug ketamine be a mental health breakthrough? It was for me

A personal account of how ketamine therapy helped with long-standing anxiety and depression.

Us Weekly · 2026

What Celebrities and Doctors Have Said About Ketamine Use

Celebrities including Chrissy Teigen, Elon Musk, Molly O’Connell and others share their experiences with ketamine therapy.

DAV · 2025

Green Beret turns to ketamine to heal invisible wounds

A Green Beret discusses how ketamine helped him recover from PTSD and reclaim daily life.

Stanford Medicine · May 2026

Drug combo is the first to prolong ketamine’s antisuicide effects

New research from Stanford shows a promising way to extend ketamine’s anti-suicidal benefits.

Billboard · July 2026

Why Grimes, Melissa Etheridge & More Artists Push Psychedelic Therapy

Musicians and artists openly discuss the potential of ketamine and other psychedelic-assisted therapies.

Rutgers University · 2024

Ketamine May Fight Chronic Fatigue, Study Suggests

New research from Rutgers suggests ketamine may help reduce symptoms of chronic fatigue.

News-Medical.net · July 2026

Ketamine Boosts Neuroplasticity Through Microglia in Female Brains

New research shows ketamine may increase neuroplasticity in female brains by activating microglia, highlighting important sex differences that could help refine future depression treatments.

Medscape News Canada · August 2026

Ketamine and Psychotherapy: A Winning Combination?

A small Toronto pilot study and the “Montreal model” explore pairing ketamine with weekly psychotherapy. Early findings suggest the combination may support neuropathic pain and help extend ketamine’s short-lived mental-health benefits.

Futurity · Texas A&M University · September 2026

How Ketamine Reshapes Brain Activity in Older Adults

Texas A&M researchers found time-specific brain-activity patterns after ketamine in older adults with treatment-resistant depression. Different information-organization patterns appeared at 1 hour, 24 hours, and 7 days. Greater brain-wide information sharing at 24 hours was linked to better symptom improvement at day 7. The work is aimed at possible biomarkers of response in late-life depression — not a guarantee of outcome.

Ready to take the next step?

Book a free consultation. No pressure — just honest answers and a clear path forward.

Book Free Consultation